Some of the documented pro-cancer effects of AGR2 relate to its ER-localized disulfide isomerase activity, which depends on its active site thioredoxin Cys residue and the KTEL C-terminal ER retention motif [112]. The gene discussed is AGR2; the disease is cancer.